University of Edinburgh
Dissecting the kinetics and plasticity of scar-associated macrophages during the progression and regression of liver fibrosis
Abstract
dc:description.abstractSingle-cell RNA sequencing has identified a pathogenic subpopulation of macrophages in the liver which reside in a distinct spatial environment named the fibrotic niche. These scar-associated macrophages (SAMacs) expand in human cirrhotic livers, are derived from circulating monocytes and can promote fibroblast proliferation and activation. However, SAMacs are associated with both fibrogenesis and fibrosis resolution via signalling to neighbouring cells within the fibrotic niche. It is not known whether different SAMac subpopulations mediate these opposing effects, or whether the same cells transition from expressing a fibrotic phenotype to a more anti-inflammatory, pro-resolution signature. In addition, the kinetics and plasticity of SAMacs have not yet been fully dissected; it therefore remains unknown how long SAMacs persist in the liver and whether these SAMacs undergo phenotypic changes during progressive and regressive liver injury. I present a novel in-vivo fate-mapping tool (Serpinb10-creERT2-Ai14) with which to selectively label monocyte-derived cells, in a temporally controlled manner, allowing us to track the kinetics and plasticity of SAMacs during fibrosis progression and regression in mice. Initially, I sought to investigate the SAMac compartment in two models (Carbon tetrachloride (CCl4) and choline-deficient, L-amino acid defined high fat-diet (CDAHFD) induced injury) of progressive and regressive murine chronic liver disease in wild-type animals. I find an expansion of SAMacs in progressive injury when compared with control (uninjured) livers, and a reduction in the SAMac compartment once injury has been withdrawn. I also observe a change in phenotype through expression of cell surface markers in SAMacs upon withdrawal of injury, together suggesting SAMacs are a dynamic compartment which change phenotype during murine chronic liver disease. Using the Serpinb10-creERT2-Ai14 transgenic murine model, I demonstrate that following recruitment, labelled SAMacs do not persist in the liver long-term and are likely replenished by cells from the circulation in ongoing injury. Finally, via transcriptomic analysis, I identify SAMacs to be plastic cells which change phenotype with increasing duration in the liver, initially expressing pro-inflammatory mediators and progressively switching to a more anti-inflammatory pro-resolution signature, irrespective of the presence of ongoing injury. My findings detail the kinetics and plasticity of the liver SAMac population and may be important in identification of promising candidate targets to modulate SAMac function in liver fibrosis. Our novel in-vivo fate mapping tool will have broad applicability to study other disease states where monocyte-derived macrophages have a role.
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Parhar, Ravinder
- Advisors dc:contributor.advisor
-
- Ramachandran, Prakash
- Henderson, Neil
Subjects
dc:subject × 8Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- https://doi.org/10.7488/era/7642